×
S&P 500   3,829.26 (-1.82%)
DOW   31,001.22 (-1.39%)
QQQ   284.14 (-2.84%)
AAPL   137.79 (-2.73%)
MSFT   257.14 (-2.93%)
META   162.93 (-3.87%)
GOOGL   2,250.22 (-2.87%)
AMZN   107.25 (-5.27%)
TSLA   701.10 (-4.58%)
NVDA   159.86 (-5.23%)
NIO   22.30 (-2.83%)
BABA   116.78 (-1.64%)
AMD   80.55 (-6.51%)
MU   58.06 (-1.22%)
CGC   3.58 (-5.54%)
T   20.61 (-0.82%)
GE   65.70 (-1.51%)
F   11.82 (-1.83%)
DIS   96.43 (-0.19%)
AMC   13.66 (-3.33%)
PFE   50.43 (-2.79%)
PYPL   71.88 (-5.35%)
NFLX   181.50 (-4.04%)
S&P 500   3,829.26 (-1.82%)
DOW   31,001.22 (-1.39%)
QQQ   284.14 (-2.84%)
AAPL   137.79 (-2.73%)
MSFT   257.14 (-2.93%)
META   162.93 (-3.87%)
GOOGL   2,250.22 (-2.87%)
AMZN   107.25 (-5.27%)
TSLA   701.10 (-4.58%)
NVDA   159.86 (-5.23%)
NIO   22.30 (-2.83%)
BABA   116.78 (-1.64%)
AMD   80.55 (-6.51%)
MU   58.06 (-1.22%)
CGC   3.58 (-5.54%)
T   20.61 (-0.82%)
GE   65.70 (-1.51%)
F   11.82 (-1.83%)
DIS   96.43 (-0.19%)
AMC   13.66 (-3.33%)
PFE   50.43 (-2.79%)
PYPL   71.88 (-5.35%)
NFLX   181.50 (-4.04%)
S&P 500   3,829.26 (-1.82%)
DOW   31,001.22 (-1.39%)
QQQ   284.14 (-2.84%)
AAPL   137.79 (-2.73%)
MSFT   257.14 (-2.93%)
META   162.93 (-3.87%)
GOOGL   2,250.22 (-2.87%)
AMZN   107.25 (-5.27%)
TSLA   701.10 (-4.58%)
NVDA   159.86 (-5.23%)
NIO   22.30 (-2.83%)
BABA   116.78 (-1.64%)
AMD   80.55 (-6.51%)
MU   58.06 (-1.22%)
CGC   3.58 (-5.54%)
T   20.61 (-0.82%)
GE   65.70 (-1.51%)
F   11.82 (-1.83%)
DIS   96.43 (-0.19%)
AMC   13.66 (-3.33%)
PFE   50.43 (-2.79%)
PYPL   71.88 (-5.35%)
NFLX   181.50 (-4.04%)
S&P 500   3,829.26 (-1.82%)
DOW   31,001.22 (-1.39%)
QQQ   284.14 (-2.84%)
AAPL   137.79 (-2.73%)
MSFT   257.14 (-2.93%)
META   162.93 (-3.87%)
GOOGL   2,250.22 (-2.87%)
AMZN   107.25 (-5.27%)
TSLA   701.10 (-4.58%)
NVDA   159.86 (-5.23%)
NIO   22.30 (-2.83%)
BABA   116.78 (-1.64%)
AMD   80.55 (-6.51%)
MU   58.06 (-1.22%)
CGC   3.58 (-5.54%)
T   20.61 (-0.82%)
GE   65.70 (-1.51%)
F   11.82 (-1.83%)
DIS   96.43 (-0.19%)
AMC   13.66 (-3.33%)
PFE   50.43 (-2.79%)
PYPL   71.88 (-5.35%)
NFLX   181.50 (-4.04%)
CVE:VHI

Vitalhub Stock Forecast, Price & News

C$2.94
+0.04 (+1.38%)
(As of 09/22/2021)
Add
Compare
Today's Range
C$2.94
C$2.99
50-Day Range
C$2.94
C$2.94
52-Week Range
C$2.17
C$3.77
Volume
8,180 shs
Average Volume
49,833 shs
Market Capitalization
C$107.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$5.00
30 days | 90 days | 365 days | Advanced Chart

Receive VHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vitalhub and its competitors with MarketBeat's FREE daily newsletter.

VHI Stock Forecast (MarketRank)

Overall MarketRank

1.61 out of 5 stars

Analyst Opinion: 2.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
Vitalhub logo

About Vitalhub (CVE:VHI)

Vitalhub Corp., together with its subsidiaries, develops technology solutions for health and human service providers in the hospital, regional health authority, mental health, long term care, home health, and community and social service sectors in Canada, the United Kingdom, and the United States. Its solutions include electronic healthcare record, case management, care coordination, patient flow and operational visibility, and DOCit mobile apps. Vitalhub Corp. is based in Toronto, Canada.

VHI Stock News Headlines

VitalHub Acquires Hicom Technology For £8.7M
IIROC Trade Resumption - VHI
See More Headlines

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
2,020
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$5.00
High Stock Price Forecast
C$5.00
Low Stock Price Forecast
C$5.00
Forecasted Upside/Downside
+70.1%
Consensus Rating
N/A
Rating Score (0-4)
3
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$19.39 million
Cash Flow
C$0.58 per share
Book Value
C$1.48 per share

Miscellaneous

Free Float
N/A
Market Cap
C$107.40 million
Optionable
Not Optionable
Beta
N/A














Vitalhub Frequently Asked Questions

What is Vitalhub's stock price forecast for 2022?

0 Wall Street analysts have issued 12-month price targets for Vitalhub's shares. Their VHI stock forecasts range from C$5.00 to C$5.00. On average, they predict Vitalhub's stock price to reach C$5.00 in the next year. This suggests a possible upside of 70.1% from the stock's current price.
View analysts' price targets for Vitalhub
or view top-rated stocks among Wall Street analysts.

How has Vitalhub's stock price performed in 2022?

Vitalhub's stock was trading at C$2.94 at the start of the year. Since then, VHI shares have increased by 0.0% and is now trading at C$2.94.
View the best growth stocks for 2022 here
.

Who are Vitalhub's key executives?

Vitalhub's management team includes the following people:
  • Mr. Daniel Matlow, Pres, CEO & Director (Age 58, Pay $361.1k)
  • Mr. Brian Goffenberg C.A., CPA, CA, CFO & Exec. VP
  • Mr. Niels Tofting, Exec. VP of Bus. Devel. & Marketing
  • Mr. Robert Lazar, Exec. VP of Professional Services & Customer Care
  • Mr. Vijit Coomara, Exec. VP of Devel.
  • Mr. Andre Vandenberk, Chief Innovations Officer (Age 60)

What other stocks do shareholders of Vitalhub own?

What is Vitalhub's stock symbol?

Vitalhub trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VHI."

How do I buy shares of Vitalhub?

Shares of VHI and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Vitalhub's stock price today?

One share of VHI stock can currently be purchased for approximately C$2.94.

How much money does Vitalhub make?

Vitalhub (CVE:VHI) has a market capitalization of C$107.40 million and generates C$19.39 million in revenue each year.

How many employees does Vitalhub have?

Vitalhub employs 2,020 workers across the globe.

How can I contact Vitalhub?

The official website for Vitalhub is vitalhub.com. The company can be reached via phone at 416-699-0123.

This page (CVE:VHI) was last updated on 6/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.